Liver Metastases Treatment Global Market Report 2025
상품코드:1825792
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
간전이 치료 시장 규모는 향후 몇 년 동안 강력한 성장이 예상됩니다. 2029년 연평균 성장률(CAGR)은 7.6%로 22억 6,000만 달러에 달할 것으로 예상됩니다. 예측 기간의 성장은 환자 중심 진료 모델, 정밀의료, 외래 및 외래 진료로의 전환, 규제 이니셔티브에 기인하는 것으로 보입니다. 예측 기간의 주요 동향으로는 차세대 시퀀싱 기술, 면역종양학의 발전, 액체 생검 기술의 등장, 보조요법 등이 있습니다.
향후 5년간 7.6%의 성장률 전망은 지난번 전망치보다 0.9% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 무역 마찰은 영국과 이스라엘에서 공급되는 마이크로파 절제 시스템 및 간동맥 주입 펌프의 가격을 급등시켜 전이성 질환 관리의 지연과 중재적 방사선 치료 비용 상승을 가져와 미국 암센터의 발목을 잡을 수 있습니다. 또한, 상호 관세와 무역 긴장과 제한의 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.
간질환 유병률의 증가는 당분간 간전이 치료 시장의 확대를 견인할 것으로 예상됩니다. 간 질환에는 간 기능을 손상시키는 다양한 장애가 포함되며, 전반적인 건강 및 대사, 해독 등 신체 기능에 위험을 초래합니다. 간전이 치료는 간 기능과 전신 건강을 유지하는 데 중요한 역할을 합니다. 장기적인 관해를 얻기 위해서는 수술적 절제, 절제술 또는 표적 치료를 포함한 종합적인 치료가 필요하며, 종종 화학요법이나 면역요법과 같은 전신 약물요법으로 보완되는 경우가 많습니다. 예를 들어, Cancer Australia는 2022년 호주에서 새로 진단될 간암 환자가 약 2,905명에 달할 것으로 보고하고 있으며, 이는 간암의 질병 부담이 크다는 것을 보여줍니다. 85세까지 간암 발병 위험이 예측되는 만큼, 간질환에 효과적으로 대처하는 것이 중요성이 강조되고 있습니다. 이처럼 간 질환의 유병률 증가는 간전이 치료 시장의 주요 촉진요인으로 작용하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 간전이 치료 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 간전이 치료 시장 : 성장률 분석
세계의 간전이 치료 시장 실적 : 규모와 성장, 2019-2024
세계의 간전이 치료 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 간전이 치료 : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 간전이 치료 시장 : 치료 종류별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
화학요법
표적요법
면역요법
세계의 간전이 치료 시장 원발성 암, 실적과 예측, 2019-2024, 2024-2029F, 2034F
대장암
유방암
세계의 간전이 치료 시장 : 유통 채널별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원 약국
전문 약국
세계의 간전이 치료 시장 : 하위 세분화 화학요법(종류별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
세포 상해성 화학요법
수술 전 화학요법
보조 화학요법
세계의 간전이 치료 시장 : 하위 세분화 표적요법(종류별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
티로신 키나아제 억제제(TKI)
단클론항체
MTOR 억제제
세계의 간전이 치료 시장 : 하위 세분화 면역요법(종류별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
면역관문억제제
암 백신
양자 세포 이식 요법
제7장 지역별·국가별 분석
세계의 간전이 치료 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 간전이 치료 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
간전이 치료 시장 : 경쟁 구도
간전이 치료 시장 : 기업 개요
Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
Merck & Co. Overview, Products and Services, Strategy and Financial Analysis
AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
Bayer AG
Sanofi S.A.
Novartis AG
Bristol Myers Squibb
AstraZeneca plc
Eli Lilly and Company
Amgen Inc.
Boehringer Ingelheim
Gilead Sciences Inc.
Takeda Pharmaceutical Company
Astellas Pharma Inc.
Daiichi Sankyo Company Ltd.
Eisai Co. Ltd.
Incyte Corporation
Ipsen
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
간전이 치료 시장 2029 : 새로운 기회를 제공하는 국가
간전이 치료 시장 2029 : 새로운 기회를 제공하는 부문
간전이 치료 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
KSM
영문 목차
영문목차
Liver metastases treatment involves therapeutic interventions targeted at managing cancerous growths that have spread to the liver from primary tumors elsewhere in the body. This comprehensive treatment strategy aims to improve patient outcomes by shrinking or eliminating metastatic lesions, alleviating symptoms, and enhancing overall quality of life.
The main types of liver metastases treatment include chemotherapy, targeted therapy, and immunotherapy. Chemotherapy is a cancer treatment approach that utilizes drugs to destroy cancer cells. It is employed for treating liver metastasis resulting from various primary cancers such as colorectal cancer and breast cancer. Chemotherapy drugs are distributed through various channels including hospital pharmacies and specialty pharmacies.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The liver metastasis treatment market research report is one of a series of new reports from The Business Research Company that provides liver metastasis treatment market statistics, including liver metastasis treatment industry global market size, regional shares, competitors with a liver metastasis treatment market share, detailed liver metastasis treatment market segments, market trends and opportunities, and any further data you may need to thrive in the liver metastasis treatment industry. This liver metastasis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The liver metastases treatment market size has grown strongly in recent years. It will grow from $1.57 billion in 2024 to $1.69 billion in 2025 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to expansion of personalized medicine, expanded access to healthcare, enhanced multidisciplinary care, clinical trials and research initiatives.
The liver metastases treatment market size is expected to see strong growth in the next few years. It will grow to $2.26 billion in 2029 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to patient-centric care models, precision medicine, shift towards outpatient, ambulatory care and regulatory initiatives. Major trends in the forecast period include next-generation sequencing technologies, immuno-oncology advancements, emergence of liquid biopsy technologies and adjuvant therapies.
The forecast of 7.6% growth over the next five years reflects a modest reduction of 0.9% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. cancer centers by inflating prices of microwave ablation systems and hepatic arterial infusion pumps sourced from the UK and Israel, resulting in delayed metastatic disease management and higher interventional radiology procedure costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The increasing incidence of liver disease is anticipated to drive the expansion of the liver metastases treatment market in the foreseeable future. Liver disease encompasses various disorders that impair the liver's function, posing risks to overall health and bodily functions such as metabolism and detoxification. Treatments for liver metastases play a critical role in preserving liver function and overall wellness. In many cases, comprehensive treatments involving surgical resection, ablation techniques, or targeted therapies are necessary for achieving long-term remission, often complemented by systemic medications such as chemotherapy or immunotherapy. For example, Cancer Australia reported approximately 2,905 new cases of liver cancer diagnosed in Australia in 2022, indicating a significant burden of the disease. The predicted risk of developing liver cancer by age 85 underscores the importance of addressing liver disease effectively. Thus, the increasing prevalence of liver disease acts as a key driver for the liver metastases treatment market.
Leading companies in the liver metastases treatment market are focused on introducing liver-directed therapies to provide effective and convenient treatment options. Liver-directed therapies specifically target liver-related diseases or conditions, aiding in the management of liver metastases by directly targeting cancerous cells within the liver. These therapies encompass various approaches, including surgical resection, radiofrequency ablation, transarterial chemoembolization, radioembolization, and stereotactic body radiation therapy. For instance, Delcath Systems Incorporated launched the Hepzato kit in August 2023, a liver-directed treatment for adult patients with metastatic uveal melanoma affecting less than 50% of the liver. The kit delivers melphalan, a chemotherapeutic agent, directly to the liver through Delcath's Hepatic Delivery System, offering targeted treatment while minimizing systemic toxicity.
In August 2023, TriSalus Life Sciences completed its merger with MedTech Acquisition Corporation, underscoring its commitment to advancing innovative treatments for liver and pancreatic tumors. TriSalus Life Sciences specializes in developing proprietary delivery technologies that enable precise and targeted delivery of immunotherapy agents directly to tumor sites, maximizing therapeutic efficacy while minimizing systemic side effects. The merger with MedTech Acquisition Corporation, a blank check company, signifies a strategic move aimed at accelerating the development and commercialization of novel treatments for liver and pancreatic tumors.
Major companies operating in the liver metastases treatment market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co., AbbVie Inc., Bayer AG, Sanofi S.A., Novartis AG, Bristol Myers Squibb, AstraZeneca plc, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim, Gilead Sciences Inc., Takeda Pharmaceutical Company, Astellas Pharma Inc., Daiichi Sankyo Company Ltd., Eisai Co. Ltd., Incyte Corporation, Ipsen, Seattle Genetics, Exelixis Inc., Array BioPharma Inc., Genentech Inc., Clovis Oncology, Agios Pharmaceuticals Inc., Taiho Pharmaceutical Co.Ltd
North America was the largest region in the liver metastases treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the liver metastases treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the liver metastases treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The liver metastases treatment market consists of revenues earned by entities by providing services such as surgery, radiotherapy, palliative care, diagnostic imaging, biopsy, ablation therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The liver metastases treatment market also includes sales of therasphere, sir-spheres gamma-90 resin microspheres, Avastin, Nexavar, Keytruda, radiofrequency ablation devices, and cyberknife. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Liver Metastases Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on liver metastases treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for liver metastases treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The liver metastases treatment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Treatment Type: Chemotherapy; Targeted Therapy; Immunotherapy
2) By Primary Cancer: Colorectal Cancer; Breast Cancer
3) By Distribution Channel: Hospital Pharmacies; Specialty Pharmacies
Subsegments:
1) By Chemotherapy: Cytotoxic Chemotherapy; Neoadjuvant Chemotherapy; Adjuvant Chemotherapy
3. Liver Metastases Treatment Market Trends And Strategies
4. Liver Metastases Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Liver Metastases Treatment Growth Analysis And Strategic Analysis Framework
5.1. Global Liver Metastases Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Liver Metastases Treatment Market Growth Rate Analysis
5.4. Global Liver Metastases Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Liver Metastases Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Liver Metastases Treatment Total Addressable Market (TAM)
6. Liver Metastases Treatment Market Segmentation
6.1. Global Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Chemotherapy
Targeted Therapy
Immunotherapy
6.2. Global Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Colorectal Cancer
Breast Cancer
6.3. Global Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Specialty Pharmacies
6.4. Global Liver Metastases Treatment Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cytotoxic Chemotherapy
Neoadjuvant Chemotherapy
Adjuvant Chemotherapy
6.5. Global Liver Metastases Treatment Market, Sub-Segmentation Of Targeted Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Tyrosine Kinase Inhibitors (TKIs)
Monoclonal Antibodies
MTOR Inhibitors
6.6. Global Liver Metastases Treatment Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Immune Checkpoint Inhibitors
Cancer Vaccines
Adoptive Cell Transfer Therapy
7. Liver Metastases Treatment Market Regional And Country Analysis
7.1. Global Liver Metastases Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Liver Metastases Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Liver Metastases Treatment Market
9.1. China Liver Metastases Treatment Market Overview
9.2. China Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Liver Metastases Treatment Market
10.1. India Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Liver Metastases Treatment Market
11.1. Japan Liver Metastases Treatment Market Overview
11.2. Japan Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Liver Metastases Treatment Market
12.1. Australia Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Liver Metastases Treatment Market
13.1. Indonesia Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Liver Metastases Treatment Market
14.1. South Korea Liver Metastases Treatment Market Overview
14.2. South Korea Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Liver Metastases Treatment Market
15.1. Western Europe Liver Metastases Treatment Market Overview
15.2. Western Europe Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Liver Metastases Treatment Market
16.1. UK Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Liver Metastases Treatment Market
17.1. Germany Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Liver Metastases Treatment Market
18.1. France Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Liver Metastases Treatment Market
19.1. Italy Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Liver Metastases Treatment Market
20.1. Spain Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Liver Metastases Treatment Market
21.1. Eastern Europe Liver Metastases Treatment Market Overview
21.2. Eastern Europe Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Liver Metastases Treatment Market
22.1. Russia Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Liver Metastases Treatment Market
23.1. North America Liver Metastases Treatment Market Overview
23.2. North America Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Liver Metastases Treatment Market
24.1. USA Liver Metastases Treatment Market Overview
24.2. USA Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.2. Canada Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Liver Metastases Treatment Market
26.1. South America Liver Metastases Treatment Market Overview
26.2. South America Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Liver Metastases Treatment Market
27.1. Brazil Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Liver Metastases Treatment Market
28.1. Middle East Liver Metastases Treatment Market Overview
28.2. Middle East Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Liver Metastases Treatment Market
29.1. Africa Liver Metastases Treatment Market Overview
29.2. Africa Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Liver Metastases Treatment Market Competitive Landscape And Company Profiles
